首页 | 本学科首页   官方微博 | 高级检索  
     

MRI基于2023版国际妇产科联盟分期评估子宫内膜癌进展
引用本文:刘晓怡,王珂,苟心怡,王屹,洪楠,程瑾. MRI基于2023版国际妇产科联盟分期评估子宫内膜癌进展[J]. 中国医学影像技术, 2024, 40(4): 622-625
作者姓名:刘晓怡  王珂  苟心怡  王屹  洪楠  程瑾
作者单位:北京大学人民医院放射科, 北京 100044
摘    要:子宫内膜癌(EC)是常见妇科恶性肿瘤;MRI对EC评估具有重要价值。2023年国际妇产科联盟(FIGO)分期做出重大修订,以更细致地对EC进行风险分层,也使MRI面临新的挑战。本文就MRI基于2023版FIGO分期评估EC进展进行综述。

关 键 词:子宫内膜肿瘤  肿瘤分期  磁共振成像
收稿时间:2023-12-07
修稿时间:2023-12-26

Progresses of MRI evaluating endometrial cancer based on 2023 International Federation of Gynecology and Obstetrics staging
LIU Xiaoyi,WANG Ke,GOU Xinyi,WANG Yi,HONG Nan,CHENG Jin. Progresses of MRI evaluating endometrial cancer based on 2023 International Federation of Gynecology and Obstetrics staging[J]. Chinese Journal of Medical Imaging Technology, 2024, 40(4): 622-625
Authors:LIU Xiaoyi  WANG Ke  GOU Xinyi  WANG Yi  HONG Nan  CHENG Jin
Affiliation:Department of Radiology, Peking University People''s Hospital, Beijing 100044, China
Abstract:Endometrial cancer (EC) is a common gynecological malignancy. MRI plays an important role for evaluation of EC. In 2023, International Federation of Gynecology and Obstetrics (FIGO) staging was significantly modified to perform more detailed risk stratification of EC, which brought new challenges to MRI. The progresses of MRI for evaluating EC based on 2023 FIGO staging were reviewed in this article.
Keywords:endometrial neoplasms  neoplasm staging  magnetic resonance imaging
点击此处可从《中国医学影像技术》浏览原始摘要信息
点击此处可从《中国医学影像技术》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号